Lakefront Biotherapeutics (LKFT) Gross Margin (QoQ) (2021 - 2026)

Lakefront Biotherapeutics (LKFT) Gross Margin (QoQ) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Lakefront Biotherapeutics 1.85 Bn -1.64 Bn 1.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -7,400.00
Dec 31, 2025 1,519.00
Sep 30, 2025 -803.00
Jun 30, 2025 1,110.00
Mar 31, 2025 -353.00
Dec 31, 2024 -572.00
Sep 30, 2024 -801.00
Jun 30, 2024 303.00
Mar 31, 2024 1,195.00
Dec 31, 2023 -665.00
Sep 30, 2023 -234.00
Jun 30, 2023 -95.00
Mar 31, 2023 -381.00
Dec 31, 2022 743.00
Sep 30, 2022 261.00
Jun 30, 2022 788.00
Mar 31, 2022 -1,980.00
Dec 31, 2021 1,107.00
Sep 30, 2021 -1,143.00
Jun 30, 2021 -4.00